OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 140 citing articles:

Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Seyed Fazel Nabavi, Nady Braidy, Olga Gortzi, et al.
Brain Research Bulletin (2015) Vol. 119, pp. 1-11
Closed Access | Times Cited: 400

An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Stephen D. Skaper, Laura Facci, Morena Zusso, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 387

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders
Theoharis C. Theoharides, Irene Tsilioni, Arti Patel, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 6, pp. e844-e844
Open Access | Times Cited: 199

Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187

Phytochemicals and cognitive health: Are flavonoids doing the trick?
Ioannis Bakoyiannis, Afrodite Daskalopoulou, Vasilios Pergialiotis, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 1488-1497
Open Access | Times Cited: 164

Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj, Ramasamy Thangavel, Deepak D. Kempuraj, et al.
BioFactors (2020) Vol. 47, Iss. 2, pp. 190-197
Closed Access | Times Cited: 163

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 128

Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism
Zhenyu Wang, Maomao Zeng, Zhaojun Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 5, pp. 1441-1454
Closed Access | Times Cited: 122

Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration
Irene Molina-González, R. Holloway, Zoeb Jiwaji, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 53

Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines
Pio Conti, Cristian D’Ovidio, Chiara Conti, et al.
European Journal of Pharmacology (2018) Vol. 844, pp. 87-94
Closed Access | Times Cited: 131

Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
Theoharis C. Theoharides, Irene Tsilioni, Mona Abubakr Bawazeer
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 122

Lipedema: friend and foe
Yanira Sanchez-De la Torre, Rita Wadeea, Victoria Rosas, et al.
Hormone Molecular Biology and Clinical Investigation (2018) Vol. 33, Iss. 1
Open Access | Times Cited: 119

Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Stephen D. Skaper, Laura Facci, Morena Zusso, et al.
The Neuroscientist (2017) Vol. 23, Iss. 5, pp. 478-498
Open Access | Times Cited: 110

Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells
Irene Tsilioni, I. Jon Russell, Julia M. Stewart, et al.
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 356, Iss. 3, pp. 664-672
Open Access | Times Cited: 108

Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
Theoharis C. Theoharides, Irene Tsilioni, Huali L. Ren
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 6, pp. 639-656
Open Access | Times Cited: 101

Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes
Aarane M. Ratnaseelan, Irene Tsilioni, Theoharis C. Theoharides
Clinical Therapeutics (2018) Vol. 40, Iss. 6, pp. 903-917
Open Access | Times Cited: 91

What is brain fog?
Laura McWhirter, Heather Smyth, Ingrid Hoeritzauer, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 94, Iss. 4, pp. 321-325
Open Access | Times Cited: 46

Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID
Emily E. Chasco, Kimberly Dukes, DeShauna Jones, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 15499-15499
Open Access | Times Cited: 44

The cognitive and psychiatric subacute impairment in severe Covid-19
Pedro Jesús Serrano Castro, F.J. Garzón-Maldonado, Ignacio Casado-Naranjo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38

The neurobiology of SARS-CoV-2 infection
Jenny Meinhardt, Simon Streit, Carsten Dittmayer, et al.
Nature reviews. Neuroscience (2023) Vol. 25, Iss. 1, pp. 30-42
Closed Access | Times Cited: 33

A multiscale inflammatory map: linking individual stress to societal dysfunction
Yoram Vodovotz, Julia Arciero, Paul F. M. J. Verschure, et al.
Frontiers in Science (2024) Vol. 1
Open Access | Times Cited: 10

Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 8

Fibromyalgia Syndrome in Need of Effective Treatments
Theoharis C. Theoharides, Irene Tsilioni, Lauren Arbetman, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 355, Iss. 2, pp. 255-263
Open Access | Times Cited: 84

Page 1 - Next Page

Scroll to top